Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
暂无分享,去创建一个
[1] I. Foeldvari,et al. The German etanercept registry for treatment of juvenile idiopathic arthritis , 2004, Annals of the rheumatic diseases.
[2] G. Firestein,et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist , 2004, The Lancet.
[3] J. Verbsky,et al. Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. , 2004, The Journal of rheumatology.
[4] M. Torrisi,et al. Phospholipases C and A2 control lysosome-mediated IL-1 beta secretion: Implications for inflammatory processes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Genovese,et al. Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate. , 2004, Arthritis and rheumatism.
[6] A Ravelli,et al. Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.
[7] P. Emery,et al. Lack of response to anakinra in rheumatoid arthritis following failure of tumor necrosis factor alpha blockade. , 2004, Arthritis and rheumatism.
[8] Marlene Wolf,et al. Chemokines: multiple levels of leukocyte migration control. , 2004, Trends in immunology.
[9] P. Hawkins,et al. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. , 2004, Arthritis and rheumatism.
[10] D. Kastner,et al. Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] A. Martini,et al. Early predictors of outcome in juvenile idiopathic arthritis. , 2003, Clinical and experimental rheumatology.
[12] A. Naya,et al. CCR1 chemokine receptor antagonist. , 2003, Current pharmaceutical design.
[13] A. Prieur,et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. , 2003, Arthritis and rheumatism.
[14] Virginia Pascual,et al. Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood , 2003, The Journal of experimental medicine.
[15] D. McCurdy,et al. Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. , 2003, The Journal of rheumatology.
[16] R. Schneider,et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. , 2003, Arthritis and rheumatism.
[17] E. Remmers,et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.
[18] C. Dinarello,et al. The IL-1 family and inflammatory diseases. , 2002, Clinical and experimental rheumatology.
[19] R. Schneider,et al. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis. , 2002, The Journal of rheumatology.
[20] Y. Iwakura,et al. Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. , 2002, Arthritis and rheumatism.
[21] K. Onel,et al. Thalidomide therapy for recalcitrant systemic onset juvenile rheumatoid arthritis. , 2002, The Journal of pediatrics.
[22] Virginia Pascual,et al. Induction of Dendritic Cell Differentiation by IFN-α in Systemic Lupus Erythematosus , 2001, Science.
[23] P. Woo,et al. Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. , 2001, Clinical and experimental rheumatology.
[24] V. Pascual,et al. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. , 2001, Science.
[25] R. Schneider,et al. Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study. , 2000, Arthritis and rheumatism.
[26] T. Lehman. Clinical trials for the treatment of systemic onset juvenile rheumatoid arthritis-juvenile idiopathic arthritis , 2000, Current rheumatology reports.
[27] Andre Peeters,et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis , 2000 .
[28] A. Reiff,et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. , 2000, The New England journal of medicine.
[29] R. Cimaz,et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. , 2000, The Journal of rheumatology.
[30] S. Nakae,et al. Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–Deficient Mice , 2000, The Journal of experimental medicine.
[31] A. Adebajo,et al. The use of intravenous pulsed methylprednisolone in the treatment of systemic-onset juvenile chronic arthritis. , 1998, British journal of rheumatology.
[32] A. Stagg,et al. Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis. , 1998, British journal of rheumatology.
[33] Wallace Ca,et al. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. , 1991 .
[34] A. Martini,et al. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. , 1991, Arthritis and rheumatism.
[35] C. Wallace,et al. Juvenile rheumatoid arthritis: outcome and treatment for the 1990s. , 1991, Rheumatic diseases clinics of North America.
[36] Audrey M. Nelson,et al. Textbook of Pediatric Rheumatology , 1990 .
[37] J. Fries,et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. , 1986, Arthritis and rheumatism.